Unichem Laboratories share news and announcements
NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap
Last close ₹472.95down ₹14.80 (3.03%)BSE ₹471.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.
52-week range of traded prices to 23 Oct 2026
₹278.20Low, 30 Mar 2026₹687.20High, 9 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,330 Cr1,036th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 10.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 11.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 40,08440.7% delivered
Unichem Laboratories board meetings
135 filed, newest first. Page 2 of 3.
Jul 2018
May 2018
29 May · Board meeting
Apr 2018
Mar 2018
31 Mar · Board meeting
Feb 2018
5 Feb · Board meeting
Jan 2018
8 Jan · Board meeting
Dec 2017
Nov 2017
3 Nov · Board meeting
Oct 2017
13 Oct · Board meeting
Not held on this date
Jul 2017
May 2017
30 May · Board meeting
Apr 2017
Jan 2017
Oct 2016
Jul 2016
23 Jul · Board meeting
May 2016
Apr 2016
Mar 2016
Jan 2016
Oct 2015
Jun 2015
May 2015
Apr 2015
28 Apr · Board meeting
Interalia consider the following: i. Consider and approve the Audited Financial Results of the Company for the year ended March 31, 2015. ii. Recommendation of final Dividend if any.
Mar 2015
Jan 2015
6 Jan · Board meeting
Inter-alia, to consider and take on record Un-Audited Results for the quarter and nine months ended December 31, 2014.
Oct 2014
7 Oct · Board meeting
Inter alia, to consider and take on record Un-Audited Accounts for the quarter and half year ended September 30, 2014.Further, that pursuant to the Code of Conduct adopted by the Company under SEBI(Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the equity shares of the Company will remain closed from October 08, 2014 to October 18, 20147 (both days inclusive) and shall open 24 hours after said financial results are made public. Accordingly, Directors / Designated employees shall not trade in the equity shares of the Company during the above said period.
Jul 2014
May 2014
16 May · Board meeting
Board of Directors of the Company at its meeting held on May 10, 2014, has considered the following: (1) Recommended the Appointment of B.D, Jokhakar & Co. as statutory auditors of the Company for period of three consecutive years from the conclusion of the ensuing Annual General Meeting subject to the approval of the Shareholders at the ensuing AGM.13 May · Board meeting
Board of Directors of the Company at its meeting held on May 10, 2014, inter alia, has also considered the following: 1) Appointment of Mr. Prafull Anubhai, Mr. Ramdas M. Gandhi, Mr. Nasser Munjee, Mr. Prafull D. Sheth and Mr. Anand Mahajan existing Independent Directors, as Independent Directors of the Company, for a term of 5 consecutive years starting from July 12, 2014 subject to approval of the shareholders at the ensuing AGM. 2) Recommended the Appointment of B. D. Jokhakar & Co., as statutory auditors of the Company for a period of three consecutive years from the conclusion of the ensuing Annual General Meeting, subject to the approval of the shareholders at the ensuing AGM.13 May · Board meeting
Board of Directors of the Company in its meeting held on March 10, 2014, allotted and issued 30,250 equity shares of Rs. 2/- each pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2008 of the company.
Apr 2014
28 Apr · Board meeting
Inter-alia, to consider and take on record the Audited Accounts for the year ended March 31, 2014 and recommendation of final dividend if any.
Mar 2014
Jan 2014
6 Jan · Board meeting
Inter-alia, to consider and take on record Un-Audited Accounts for the quarter ended December 31, 2013 and to consider interim dividend, if any for the financial year 2013-14.
Oct 2013
10 Oct · Board meeting
Inter-alia, to consider and take on record the Un-audited Accounts for the year ended September 30, 2013.
Jul 2013
8 Jul · Board meeting
Inter alia, to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended June 30, 2013.1 Jul · Board meeting
Board of directors in its meeting held on June 29, 2013, allotted and issued 88,788 equity shares of Rs. 2/- each pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2008 of the Company.
May 2013
13 May · Board meeting
Board of Directors of the Company at its meeting held on May 11, 2013, inter alia, has considered the following:(1) Allotted and issued 13,750 equity shares of Rs. 2/- each pursuant to the exercise of the Stock Option Scheme - 2008 of the Company.
Mar 2013
20 Mar · Board meeting
Board of Directors in its meeting held on March 20, 2013, allotted and issued 8,312 equity shares of Rs. 2/- each pursuant to exercise of the stock options by the eligible employees under the Employee Stock option Scheme 2004 and Employee Stock option Scheme 2008 of the Company.
Feb 2013
Jan 2013
8 Jan · Board meeting
Inter-alia, to consider and take on record the Un-audited Financial Results of the Company for the quarter ended December 31, 2012.
Oct 2012
9 Oct · Board meeting
Inter-alia to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended September 30, 2012.